{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:02:19Z","timestamp":1790712139959,"version":"4.1.0"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T00:00:00Z","timestamp":1589414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"DOI":"10.3389\/fcell.2020.00326","type":"journal-article","created":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T01:13:37Z","timestamp":1589418817000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":52,"title":["Mesenchymal Stem Cells and Atopic Dermatitis: A Review"],"prefix":"10.3389","volume":"8","author":[{"given":"S\u00e9rgio Ricardo Teixeira","family":"Daltro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e1ssio Santana","family":"Meira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivanilson Pimenta","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Ribeiro dos Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena Botelho Pereira","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","article-title":"Human mesenchymal stem cells modulate allogeneic immune cell responses.","volume":"105","author":"Aggarwal","year":"2005","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bpobgyn.2015.08.014","article-title":"Placental stem cells.","volume":"31","author":"Antoniadou","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1590\/abd1806-4841.2019940210","article-title":"Consensus on the therapeutic management of atopic dermatitis- Brazilian Society of Dermatology.","volume":"94","author":"Aoki","year":"2019","journal-title":"An. Bras. Dermatol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007770.pub2","article-title":"Oral H1 antihistamines as monotherapy for eczema.","volume":"28","author":"Apfelbacher","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.exphem.2009.01.005","article-title":"Mesenchymal stem cells suppress B-cell terminal differentiation.","volume":"37","author":"Asari","year":"2009","journal-title":"Exp. Hematol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.cellimm.2015.07.001","article-title":"Mesenchymal stromal cells improve early lymphocyte recovery and T cell reconstitution after autologous hematopoietic stem cells transplatation in patients with malignant lymphomas.","volume":"297","author":"Batorov","year":"2015","journal-title":"Cell. Immunol."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7403.1367","article-title":"Twice weekly fluticasone propionate added to emolient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study.","volume":"326","author":"Berth-Jones","year":"2003","journal-title":"BMJ"},{"key":"B8","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1634\/stemcells.19-3-180","article-title":"Bone marrow stromal stem cells: nature, biology, and potential applications.","volume":"19","author":"Bianco","year":"2001","journal-title":"Stem Cells"},{"key":"B9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-3-319-64804-0_3","article-title":"Atopic dermatitis: pathophysiology.","volume":"1027","author":"Boothe","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/975871","article-title":"Markers for characterization of bone marrow multipotential stromal cells.","volume":"2012","author":"Boxall","year":"2012","journal-title":"Stem Cells Int."},{"key":"B11","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1365-2222.2010.03685.x","article-title":"Bone marrow stromal cells inhibit mast cell function via a COX2-dependent mechanism.","volume":"41","author":"Brown","year":"2011","journal-title":"Clin. Exp. Allergy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/15384101.2019.1707455","article-title":"Skin immunity and its dysregulation in atopic dermatitis, hidradenitis supurativa and vitiligo.","volume":"19","author":"Campione","year":"2020","journal-title":"Cell Cycle"},{"key":"B13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s40272-013-0013-9","article-title":"Topical calcineurin inhibitors for atopic dermatitis: review and treatment recomendations.","volume":"15","author":"Carr","year":"2013","journal-title":"Paediatr. Drugs"},{"key":"B14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1525-1470.2005.22303.x","article-title":"The burden of atopic dermatitis: impact on the patient, family, and society.","volume":"22","author":"Carroll","year":"2005","journal-title":"Pediatr. Dermatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1634\/stemcells.2007-0197","article-title":"Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing.","volume":"25","author":"Chamberlain","year":"2007","journal-title":"Stem Cells"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/vde.12762","article-title":"Alterations in circulating concentrations of IL-17, IL-31 and total IgE in dogs with atopic dermatitits.","volume":"30","author":"Chaudhary","year":"2019","journal-title":"Vet. Dermatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"17384","DOI":"10.1073\/pnas.1103650108","article-title":"Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells.","volume":"108","author":"Chiesa","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-018-0939-5","article-title":"Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis.","volume":"9","author":"Cho","year":"2018","journal-title":"Stem Cells Res. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1006\/bbrc.2001.4976","article-title":"Structure and expression of the human histamine H4-receptor gene.","volume":"284","author":"Cog\u00e9","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","article-title":"Human mesenchymal stem cells modulate B-cell functions.","volume":"107","author":"Corcione","year":"2005","journal-title":"Blood"},{"key":"B21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.2174\/156652412800619950","article-title":"Immunosuppressive properties of mesenchymal stem cells: advances and applications.","volume":"12","author":"De Miguel","year":"2012","journal-title":"Curr. Mol. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1182\/blood.v99.10.3838","article-title":"Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli.","volume":"99","author":"Di Nicola","year":"2002","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-019-2087-2","article-title":"Mesenchymal stem cells therapy in companion animals: useful for immune-mediated diseases?","volume":"15","author":"Dias","year":"2019","journal-title":"BMC Vet. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement.","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"B25","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jaad.2013.10.010","article-title":"Guidelines of care for the management of atopic dermatitis: section 1. diagnosis and assessment of atopic dermatitis.","volume":"70","author":"Eichenfield","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.sder.2012.07.006","article-title":"Understanding and managing atopic dermatitis in adult patients.","volume":"31","author":"Ellis","year":"2012","journal-title":"Semin. Cutan. Med. Surg."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1182\/blood-2005-07-2772","article-title":"Human mast cells express multiple EP receptors for prostaglandina E2 that differentially modulate activation responses.","volume":"107","author":"Feng","year":"2006","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/j.1365-2184.1970.tb00347.x","article-title":"The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells.","volume":"3","author":"Friedenstein","year":"1970","journal-title":"Cell Tissue Kinet."},{"key":"B29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4252\/wjsc.v6.i5.526","article-title":"Mesenchymal stem cells: emerging mechanisms of immunomodulation and therapy.","volume":"26","author":"Glenn","year":"2014","journal-title":"World J. Stem Cells"},{"key":"B30","doi-asserted-by":"publisher","first-page":"22","DOI":"10.2174\/1574888X13666180913123424","article-title":"The clinical trials of mesenchymal stem cell therapy in skin diseases: an update and concise review.","volume":"14","author":"Golchin","year":"2019","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"B31","doi-asserted-by":"publisher","first-page":"5987","DOI":"10.4049\/jimmunol.174.10.5987","article-title":"TGF-beta 1 inhibits mast cell Fc epsilon RI expression.","volume":"174","author":"Gomez","year":"2005","journal-title":"J. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1016\/j.archoralbio.2011.05.008","article-title":"Mesenchymal and embryonic characteristics of stem cells obtained from mouse dental pulp.","volume":"56","author":"Guimar\u00e3es","year":"2011","journal-title":"Arch. Oral Biol."},{"key":"B33","first-page":"E1","article-title":"Evaluation of the potential use of adipose-derived mesenchymal stromal cells in the treatment of canine atopic dermatitis: a pilot study.","volume":"11","author":"Hall","year":"2010","journal-title":"Vet. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s0091-6749(96)70246-4","article-title":"In vivo expression of IL-12 and IL-13 in atopic dermatitis.","volume":"98","author":"Hamid","year":"1996","journal-title":"J. Allergy Clin. Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/s0190-9622(99)70410-x","article-title":"Bichemical and imunologic mechanisms in atopic dermatitis: new targets for emerging therapies.","volume":"41","author":"Hanifin","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1590\/S0100-879X2010007500033","article-title":"Immunomodulatory effect of mesenchymal stem cells.","volume":"43","author":"Herrero","year":"2010","journal-title":"Braz. J. Med. Biol. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bjd.14588","article-title":"Systematic review of treatments for atopic eczema.","volume":"4","author":"Hoare","year":"2000","journal-title":"Health Technol. Assess."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semarthrit.2016.02.008","article-title":"Immunomodulatory properties of mesenchymal stem cell in experimental arthritis in rat and mouse models: a systematic review.","volume":"46","author":"Hypnes","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-018-0281-6","article-title":"Atopic dermatitis.","volume":"14","author":"Kapur","year":"2018","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/sj.bjp.0706664","article-title":"Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.","volume":"147","author":"Kay","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ebiom.2018.01.002","article-title":"Enhanced immunosuppressive properties of human mesenchymal stem cells primed by interferon-\u03b3.","volume":"28","author":"Kim","year":"2018","journal-title":"EBioMedicine"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01175","article-title":"Human adipose tissue-derived mesenchymal stem cells attenuate atopic dermatitis by regulating the expression of MIP-2, miR-122a-SOCS1 axis, and Th1\/Th2 responses.","volume":"9","author":"Kim","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/stem.2401","article-title":"Clinical trial of human umbilical cord blood-derived stem cells for the treatment of moderate-to-severe atopic dermatitis: phase I\/IIa studies.","volume":"35","author":"Kim","year":"2017","journal-title":"Stem Cells"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/stem.1913","article-title":"Human umbilical cord blood mesenchymal tem cell-derived PGE2 and TGF-\u03b21 alleviate atopic dermatits by reducing mast cell degranulation.","volume":"33","author":"Kim","year":"2015","journal-title":"Stem Cells"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/j.exphem.2009.09.004","article-title":"Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages.","volume":"37","author":"Kim","year":"2009","journal-title":"Exp. Hematol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.molimm.2009.11.017","article-title":"Transglutaminase II interacts with rac1, regulates production of reactive oxygen species, expression of snail, secretion of Th2 cytokines and mediates in vitro and in vivo allergic inflammation.","volume":"47","author":"Kim","year":"2010","journal-title":"Mol. Immunol."},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103086","article-title":"New cytokines in the pathogenesis of atopic dermatitis New therapeutic targets.","volume":"19","author":"Klonowska","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.7150\/thno.32945","article-title":"Disease-specific primed human adult stem cells effectively ameliorate experimental atopic dermatitis in mice.","volume":"9","author":"Lee","year":"2019","journal-title":"Theranostics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cellimm.2017.08.009","article-title":"Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutical applications.","volume":"326","author":"Lee","year":"2018","journal-title":"Cell. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1182\/blood-2003-05-1670","article-title":"Isolation of multipotent mesenchymal stem cells from umbilical cord blood.","volume":"103","author":"Lee","year":"2004","journal-title":"Blood"},{"key":"B51","doi-asserted-by":"publisher","first-page":"S99","DOI":"10.1016\/s0091-6749(99)70051-5","article-title":"Pathogenesis of atopic dermatitis.","volume":"104","author":"Leung","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1111\/j.1742-1241.2006.01047.x","article-title":"Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema.","volume":"60","author":"Lewis-Jones","year":"2006","journal-title":"Int. J. Clin. Pract."},{"key":"B53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.alit.2019.08.001","article-title":"Mesenchymal stem cells in allergic diseases: current status.","volume":"69","author":"Li","year":"2020","journal-title":"Allergol. Int."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7495135","article-title":"Umbilical cord tissue-derived mesenchymal stem cells induce lymphocyte apoptosis and cell cycle arrest by expression of indoleamine 2,3-dioxygenase.","volume":"2016","author":"Li","year":"2016","journal-title":"Stem Cells Int."},{"key":"B55","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s12016-011-8252-4","article-title":"IgE, mast cells, and eosinophils in atopic dermatitis.","volume":"41","author":"Liu","year":"2011","journal-title":"Clin. Rev. Allergy. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/stem.2553","article-title":"Concise review: amniotic fluid stem cells: the know, the unknow, and potential regenerative medicine applications.","volume":"35","author":"Loukogeorgakis","year":"2017","journal-title":"Stem Cells"},{"key":"B57","first-page":"1017","article-title":"Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoesis-supportive function and other potentials.","volume":"91","author":"Lu","year":"2006","journal-title":"Haematologica"},{"key":"B58","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/ACI.0b013e3282ffd6cc","article-title":"Quality of life of children with atopic dermatitis and their families.","volume":"8","author":"McKenna","year":"2008","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1046\/j.1440-0960.2002.00610.x","article-title":"Atopic dermatitis: review of immunopathogenesis, and advances in immunosuppressive therapy.","volume":"43","author":"Meagher","year":"2002","journal-title":"Australas. J. Dermatol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic Inflammation.","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.299","article-title":"Bone marrow-derived clonal mesenchymal stem cells inhibit ovalbumin-induced atopic dermatitis.","volume":"5","author":"Na","year":"2014","journal-title":"Cell Death Dis."},{"key":"B62","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1525-1470.1996.tb01178.x","article-title":"Frequency and significance of minor clinical features in various age-related subgroups of atopic dermatits in children.","volume":"13","author":"Nagaraja","year":"1996","journal-title":"Pediatr. Dermatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/jid.2008.192","article-title":"B-cell-directed therapy for inflammatory skin diseases.","volume":"129","author":"Nagel","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s00011-018-1131-1","article-title":"Insights into inflammatory priming of mesenchymal stromal cells: functional biological impacts.","volume":"67","author":"Najar","year":"2018","journal-title":"Inflamm. Res."},{"key":"B65","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(94)92855-X","article-title":"Tacrolimus ointment for atopic dermatitis.","volume":"344","author":"Nakagawa","year":"1994","journal-title":"Lancet"},{"key":"B66","year":"2020","journal-title":"ClinicalTrials.gov."},{"key":"B67","doi-asserted-by":"publisher","first-page":"56652","DOI":"10.1073\/pnas.0910720107","article-title":"Bone marrow stromal cells use TGF-\u03b2 to suppress allergic responses in a mouse model of ragweed-induced asthma.","volume":"107","author":"Nemeth","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B68","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000370220","article-title":"Atopic demartitis: global epidemiology and risk factors.","volume":"66","author":"Nutten","year":"2015","journal-title":"Ann. Nutr. Metab."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.jaci.2009.10.009","article-title":"Global variations in prevalence of eczema symptoms in children from ISAAC phase three.","volume":"124","author":"Odhiambo","year":"2009","journal-title":"J. Allergy Clin. Immunol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.jid.2016.05.117","article-title":"Early activation of Th2\/Th22 inflammatory and pruritogenic pathways in acute canine AD skin lesions.","volume":"136","author":"Olivry","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/bjd.15078","article-title":"T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: at the origin of the problem.","volume":"176","author":"Orciani","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"B72","first-page":"293","article-title":"Atopic dermatitis in children.","volume":"45","author":"Page","year":"2016","journal-title":"Aust. Fam. Phys."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-019-1164-6","article-title":"Priming with toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis.","volume":"10","author":"Park","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1628914","article-title":"Real-life practice: rapid improvement in itch symptomatology in patients with atopic dermatitis treated with dupilumab.","author":"Pistone","year":"2019","journal-title":"J. Dermatolog. Treat."},{"key":"B75","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells.","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"B76","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2174\/1574888X14666181205115452","article-title":"Immunomodulatory properties of mesenchymal stromal cells: still unresolved \u201cYin and Yang\u201d.","volume":"14","author":"Poggi","year":"2019","journal-title":"Curr. Stem. Cell Res. Ther."},{"key":"B77","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1634\/stemcells.2007-0416","article-title":"Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche.","volume":"26","author":"Raffaghello","year":"2008","journal-title":"Stem Cells"},{"key":"B78","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2500\/aap.2018.39.4175","article-title":"The burden of atopic dermatitis.","volume":"39","author":"Reed","year":"2018","journal-title":"Allergy Asthma Proc."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1468-3083.2012.04635.x","article-title":"Guidelines for treatment of atopic eczema (atopic dermatitis) part I.","volume":"26","author":"Ring","year":"","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/j.1468-3083.2012.04636.x","article-title":"Guidelines for treatment of atopic eczema (atopic dermatitis) part II.","volume":"26","author":"Ring","year":"","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"B81","first-page":"70","article-title":"Histamine and atopic eczema.","volume":"144","author":"Ring","year":"1989","journal-title":"Acta Derm. Venereol. Suppl."},{"key":"B82","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.clindermatol.2018.05.007","article-title":"Epidemiology of adult atopic dermatits.","volume":"36","author":"Sacotte","year":"2018","journal-title":"Clin. Dermatol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1111\/1346-8138.13392","article-title":"Clinical practice guidelines for the management of atopic dermatitis 2016.","volume":"43","author":"Saeki","year":"2016","journal-title":"J. Dermatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1111\/all.13594","article-title":"Enhanced therapeutic effects of human mesenchymal stem cells transduced with superoxide dismutase 3 in a murine topic dermatitis-like skin inflammation model allergy.","volume":"73","author":"Sah","year":"2018","journal-title":"Allergy"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms18020244","article-title":"Mesenchymal stem cell therapy for inflammatory skin diseases: clinical potential and mode of action.","volume":"18","author":"Shin","year":"","journal-title":"Int. J. Mol. Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"512","DOI":"10.18632\/oncotarget.13473","article-title":"Human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatits via regulation of B lymphocyte maturation.","volume":"8","author":"Shin","year":"","journal-title":"Oncotarget"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-017-0710-5","article-title":"Evolving concepts in atopic dermatitis.","volume":"17","author":"Sidburry","year":"2017","journal-title":"Curr. Allergy Asthma Rep."},{"key":"B88","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.det.2017.02.008","article-title":"Special considerations for therapy of pediatric atopic dermatitis.","volume":"35","author":"Silverberg","year":"2017","journal-title":"Dermatol. Clin."},{"key":"B89","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.jaci.2007.11.016","article-title":"Anti-Cd20 (rituximab) treatment improves atopic eczema.","volume":"121","author":"Simon","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s40257-017-0324-7","article-title":"Are biological efficacious in atopic dermatits? A systematic review and meta-anaylsis.","volume":"19","author":"Snast","year":"2018","journal-title":"Am. J. Clin. Dermatol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/sj.cr.7310031","article-title":"Redox regulation of mast cell histamine release in thioredoxin-1 (TRX) transgenic mice.","volume":"16","author":"Son","year":"2006","journal-title":"Cell Res."},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42964-7","article-title":"Umbilical cord-derived mesenchymal stem cell extracts ameliorate atopic dermatitis in mice by reducing the T cell responses.","volume":"9","author":"Song","year":"2019","journal-title":"Sci. Rep."},{"key":"B93","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1634\/stemcells.2004-0359","article-title":"Interactions between human mesenchymal stem cells and natural killer cells.","volume":"24","author":"Sotiropoulou","year":"2006","journal-title":"Stem Cells"},{"key":"B94","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/stem.68","article-title":"Mesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans.","volume":"27","author":"Sun","year":"2009","journal-title":"Stem Cells"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.12.441","article-title":"Intracellular superoxide production by mast cells.","volume":"121","author":"Swindle","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1136\/vr.104867","article-title":"Allogeneic adipose-derived mesenchymal stem cell therapy in dogs with refractory atopic dermatitis: clinical efficacy and safety.","volume":"183","author":"Villatoro","year":"2018","journal-title":"Vet. Rec."},{"key":"B97","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1089\/scd.2013.0023","article-title":"Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety, and efficacy.","volume":"22","author":"Wang","year":"2013","journal-title":"Stem Cells Dev."},{"key":"B98","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1398-9995.2006.01043.x","article-title":"Prostaglandin E2 potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1\/EP3 receptors.","volume":"61","author":"Wang","year":"2006","journal-title":"Allergy"},{"key":"B99","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/aps.2013.50","article-title":"Mesenchymal stem cells: a new trend for cell therapy.","volume":"34","author":"Wei","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/S0140-6736(15)00149-X","article-title":"Atopic dermatitis.","volume":"387","author":"Weidinger","year":"2016","journal-title":"Lancet"},{"key":"B101","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.regen.2018.01.001","article-title":"Dual IFN-\u03b3\/hypoxia priming enhances immunosuppression of mesenchymal stromal cells through regulatory proteins and metabolic mechanisms.","volume":"1","author":"Wobma","year":"2018","journal-title":"J. Immunol. Regen. Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1177\/1715163517710958","article-title":"Guidelines for the management of atopic dermatitis (eczema) for pharmacists.","volume":"150","author":"Wong","year":"2017","journal-title":"Can. Pharm. J."},{"key":"B103","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.vetimm.2006.08.016","article-title":"A rodent model for allergic dermatitis induced by flea antigens.","volume":"114","author":"Zhao","year":"2006","journal-title":"Vet. Immunol. Immunopathol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00441-018-2871-5","article-title":"Mesenchymal stromal cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential aplicattions in sepsis.","volume":"374","author":"Zheng","year":"2018","journal-title":"Cell Tissue Res."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00326\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T01:13:39Z","timestamp":1589418819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fcell.2020.00326\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,14]]},"references-count":104,"alternative-id":["10.3389\/fcell.2020.00326"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2020.00326","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,14]]},"article-number":"326"}}